bufalin and Lymphoma, Large B-Cell, Diffuse

bufalin has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Y; Deng, M; Han, Q; Liu, B; Lv, F; Song, J; Sui, D; Wang, S; Wang, X; Yang, C; Zhang, Y; Zhao, X; Zou, D	1

Other Studies

1 other study(ies) available for bufalin and Lymphoma, Large B-Cell, Diffuse

Article	Year
Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway. Carcinogenesis, 2021, 02-25, Volume: 42, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Calcium Signaling; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mice; NFATC Transcription Factors; Proto-Oncogene Proteins c-myc; Signal Transduction; Xenograft Model Antitumor Assays	2021

Article

Year

Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway.

Carcinogenesis, 2021, 02-25, Volume: 42, Issue:2

Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Calcium Signaling; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mice; NFATC Transcription Factors; Proto-Oncogene Proteins c-myc; Signal Transduction; Xenograft Model Antitumor Assays

2021